Financiere de Tubize operates as an investment holding company which engages in the biopharmaceuticals industry.
Financière de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 24, 2022
UCB
|
Post-IPO Equity | €94.50M | Biotechnology | Yes |